At a glance
ClinicalIndex Comparison RecordN/ACompleted· 109 enrolled
Drug / intervention
COMBI TEP : PET / enhanced CT scandevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PET / Enhanced CT Scan Performance in Cancer (Positron Emission Tomography Combined With Computed Tomography or Vascular Contrast CT Scan). COMBI TEP Study
In Brief
A clinical study evaluating COMBI TEP : PET / enhanced CT scan for Cancer Disease Progression. Completed, enrolled 109 participants.
Detailed Summary
Hypothesis: The investigators would like to demonstrate that diagnosis performance of PET/CT scan without and with contrast agent (COMBI TEP), are equivalent or better than those of PET/ non enhanced CT scan (PET scan) associated with an enhanced CT scan. This research project is a pilot study given the few available data concerning this imaging exam reproducibility. This study is a prospective single center study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer Disease Progression
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
Primary CompletionJul 2012
First PostedJun 2013
Study CompletionJul 2015
TodayJul 2026
First PostedJun 19, 2013
Enrollment StartMar 19, 2010
Primary CompletionJul 19, 2012
Study CompletionJul 15, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.0 years ago
Interventions
COMBI TEP : PET / enhanced CT scandevice
diagnostic imaging exam